Literature DB >> 18267237

Clinicopathological aspects of motor parkinsonism.

Glenda Halliday1.   

Abstract

Motor parkinsonism is characterised by bradykinesia, muscle rigidity, postural instability and resting tremor that occur most often in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy. In all three disorders the main regulators of the caudate nucleus and putamen (dopaminergic substantia nigra and glutaminergic caudal intralaminar nuclei), as well as the cortical projection from the presupplementary motor area, degenerate. Degeneration of the major basal ganglia circuit neurons also occurs in multiple system atrophy, while degeneration of the subthalamus and a widespread loss of inhibitory interneurons within the extrapyramidal system occurs in progressive supranuclear palsy.

Entities:  

Mesh:

Year:  2007        PMID: 18267237     DOI: 10.1016/S1353-8020(08)70003-8

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  6 in total

1.  Fluoxetine ameliorates behavioral and neuropathological deficits in a transgenic model mouse of α-synucleinopathy.

Authors:  Kiren Ubhi; Chandra Inglis; Michael Mante; Christina Patrick; Anthony Adame; Brian Spencer; Edward Rockenstein; Verena May; Juergen Winkler; Eliezer Masliah
Journal:  Exp Neurol       Date:  2012-01-16       Impact factor: 5.330

2.  Hypokinesia without decrement distinguishes progressive supranuclear palsy from Parkinson's disease.

Authors:  Helen Ling; Luke A Massey; Andrew J Lees; Peter Brown; Brian L Day
Journal:  Brain       Date:  2012-03-06       Impact factor: 13.501

3.  Reducing C-terminal-truncated alpha-synuclein by immunotherapy attenuates neurodegeneration and propagation in Parkinson's disease-like models.

Authors:  Dora Games; Elvira Valera; Brian Spencer; Edward Rockenstein; Michael Mante; Anthony Adame; Christina Patrick; Kiren Ubhi; Silke Nuber; Patricia Sacayon; Wagner Zago; Peter Seubert; Robin Barbour; Dale Schenk; Eliezer Masliah
Journal:  J Neurosci       Date:  2014-07-09       Impact factor: 6.167

4.  Active immunization against alpha-synuclein ameliorates the degenerative pathology and prevents demyelination in a model of multiple system atrophy.

Authors:  Markus Mandler; Elvira Valera; Edward Rockenstein; Michael Mante; Harald Weninger; Christina Patrick; Anthony Adame; Sabine Schmidhuber; Radmila Santic; Achim Schneeberger; Walter Schmidt; Frank Mattner; Eliezer Masliah
Journal:  Mol Neurodegener       Date:  2015-03-19       Impact factor: 14.195

5.  Lenalidomide reduces microglial activation and behavioral deficits in a transgenic model of Parkinson's disease.

Authors:  Elvira Valera; Michael Mante; Scott Anderson; Edward Rockenstein; Eliezer Masliah
Journal:  J Neuroinflammation       Date:  2015-05-14       Impact factor: 8.322

6.  Abnormal Resting-State Functional Connectivity in Progressive Supranuclear Palsy and Corticobasal Syndrome.

Authors:  Komal Bharti; Matteo Bologna; Neeraj Upadhyay; Maria Cristina Piattella; Antonio Suppa; Nikolaos Petsas; Costanza Giannì; Francesca Tona; Alfredo Berardelli; Patrizia Pantano
Journal:  Front Neurol       Date:  2017-06-06       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.